Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12436 | 906 | 28.8 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
12436 | 1 | ANTICONVULSANT ACTIVITY//EPILEPSY BRANCH//ANTICONVULSANTS | 906 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTICONVULSANT ACTIVITY | authKW | 1878634 | 17% | 37% | 151 |
2 | EPILEPSY BRANCH | address | 661954 | 6% | 37% | 53 |
3 | ANTICONVULSANTS | authKW | 635712 | 25% | 8% | 227 |
4 | MES TEST | authKW | 554624 | 3% | 69% | 24 |
5 | PYRROLIDINE 2 5 DIONE | authKW | 436768 | 2% | 72% | 18 |
6 | MAXIMAL ELECTROSHOCK | authKW | 425452 | 6% | 25% | 51 |
7 | SCPTZ | authKW | 335031 | 1% | 76% | 13 |
8 | SCPTZ TEST | authKW | 306380 | 1% | 91% | 10 |
9 | MAXIMAL ELECTROSHOCK TEST | authKW | 280837 | 2% | 56% | 15 |
10 | MES | authKW | 248230 | 4% | 23% | 32 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 27072 | 51% | 0% | 461 |
2 | Pharmacology & Pharmacy | 2499 | 32% | 0% | 288 |
3 | Chemistry, Multidisciplinary | 570 | 19% | 0% | 168 |
4 | Chemistry, Organic | 545 | 12% | 0% | 113 |
5 | Crystallography | 372 | 6% | 0% | 55 |
6 | Clinical Neurology | 206 | 8% | 0% | 73 |
7 | Biochemistry & Molecular Biology | 7 | 8% | 0% | 69 |
8 | Neurosciences | 1 | 4% | 0% | 33 |
9 | Spectroscopy | 0 | 1% | 0% | 7 |
10 | Biology | 0 | 1% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSY BRANCH | 661954 | 6% | 37% | 53 |
2 | ORGANISM FUNCT TORS CHANGBAI MT | 146209 | 2% | 27% | 16 |
3 | FOOD DRUG MED | 140423 | 1% | 83% | 5 |
4 | MNDJOYANS FINE ORGAN CHEM | 134808 | 0% | 100% | 4 |
5 | ISOBOLOG ANAL | 117936 | 2% | 25% | 14 |
6 | ANTICONVULSANT SCREENING PROGRAM | 110292 | 1% | 55% | 6 |
7 | CORP DEV ASTA MED GRP | 101106 | 0% | 100% | 3 |
8 | PRECLIN PHARMACOL SECT | 89101 | 3% | 12% | 23 |
9 | PAUL CAROLE STARK NEUROSCI | 71825 | 1% | 24% | 9 |
10 | ADESH PHARM BIOMED SCI | 67404 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MEDICINAL CHEMISTRY RESEARCH | 36916 | 7% | 2% | 59 |
2 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 27387 | 10% | 1% | 87 |
3 | ACTA POLONIAE PHARMACEUTICA | 14681 | 3% | 2% | 25 |
4 | ARCHIV DER PHARMAZIE | 14444 | 5% | 1% | 43 |
5 | LETTERS IN DRUG DESIGN & DISCOVERY | 11001 | 2% | 2% | 21 |
6 | PHARMACOLOGICAL REPORTS | 6763 | 2% | 1% | 19 |
7 | EPILEPSY RESEARCH | 6311 | 3% | 1% | 27 |
8 | MEDICINAL CHEMISTRY | 4628 | 1% | 1% | 11 |
9 | JOURNAL OF MEDICINAL CHEMISTRY | 4354 | 6% | 0% | 53 |
10 | BIOORGANIC & MEDICINAL CHEMISTRY | 3317 | 4% | 0% | 36 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTICONVULSANT ACTIVITY | 1878634 | 17% | 37% | 151 | Search ANTICONVULSANT+ACTIVITY | Search ANTICONVULSANT+ACTIVITY |
2 | ANTICONVULSANTS | 635712 | 25% | 8% | 227 | Search ANTICONVULSANTS | Search ANTICONVULSANTS |
3 | MES TEST | 554624 | 3% | 69% | 24 | Search MES+TEST | Search MES+TEST |
4 | PYRROLIDINE 2 5 DIONE | 436768 | 2% | 72% | 18 | Search PYRROLIDINE+2+5+DIONE | Search PYRROLIDINE+2+5+DIONE |
5 | MAXIMAL ELECTROSHOCK | 425452 | 6% | 25% | 51 | Search MAXIMAL+ELECTROSHOCK | Search MAXIMAL+ELECTROSHOCK |
6 | SCPTZ | 335031 | 1% | 76% | 13 | Search SCPTZ | Search SCPTZ |
7 | SCPTZ TEST | 306380 | 1% | 91% | 10 | Search SCPTZ+TEST | Search SCPTZ+TEST |
8 | MAXIMAL ELECTROSHOCK TEST | 280837 | 2% | 56% | 15 | Search MAXIMAL+ELECTROSHOCK+TEST | Search MAXIMAL+ELECTROSHOCK+TEST |
9 | MES | 248230 | 4% | 23% | 32 | Search MES | Search MES |
10 | AMELTOLIDE | 206423 | 1% | 88% | 7 | Search AMELTOLIDE | Search AMELTOLIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WEI, CX , BIAN, M , GONG, GH , (2015) CURRENT RESEARCH ON ANTIEPILEPTIC COMPOUNDS.MOLECULES. VOL. 20. ISSUE 11. P. 20741 -20776 | 109 | 64% | 1 |
2 | AYATI, A , EMAMI, S , FOROUMADI, A , (2016) THE IMPORTANCE OF TRIAZOLE SCAFFOLD IN THE DEVELOPMENT OF ANTICONVULSANT AGENTS.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 109. ISSUE . P. 380 -392 | 45 | 52% | 5 |
3 | MALAWSKA, B , (2005) NEW ANTICONVULSANT AGENTS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 5. ISSUE 1. P. 69-85 | 59 | 58% | 109 |
4 | BANERJEE, PS , SHARMA, PK , (2012) NEW ANTIEPILEPTIC AGENTS: STRUCTURE-ACTIVITY RELATIONSHIPS.MEDICINAL CHEMISTRY RESEARCH. VOL. 21. ISSUE 7. P. 1491-1508 | 56 | 54% | 6 |
5 | PANDEY, S , SRIVASTAVA, RS , (2010) RECENT ADVANCEMENT IN THE FIELD OF ANTICONVULSANTS: A REVIEW.LETTERS IN DRUG DESIGN & DISCOVERY. VOL. 7. ISSUE 9. P. 694 -706 | 51 | 57% | 5 |
6 | DALKARA, S , KARAKURT, A , (2012) RECENT PROGRESS IN ANTICONVULSANT DRUG RESEARCH: STRATEGIES FOR ANTICONVULSANT DRUG DEVELOPMENT AND APPLICATIONS OF ANTIEPILEPTIC DRUGS FOR NON-EPILEPTIC CENTRAL NERVOUS SYSTEM DISORDERS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 12. ISSUE 9. P. 1033 -1071 | 66 | 36% | 16 |
7 | AHSAN, W , SAFHI, MM , SIDDIQUI, N , JAVED, S , ALAM, MS , AZAD, B , AKHTAR, J , (2012) AN INSIGHT INTO THE NEW ANTICONVULSANT AGENTS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 12. ISSUE 9. P. 1072-1092 | 53 | 47% | 2 |
8 | KAMINSKI, K , WIKLIK, B , OBNISKA, J , (2014) SYNTHESIS, ANTICONVULSANT PROPERTIES, AND SAR ANALYSIS OF DIFFERENTLY SUBSTITUTED PYRROLIDINE-2,5-DIONES AND PIPERIDINE-2,6-DIONES.ARCHIV DER PHARMAZIE. VOL. 347. ISSUE 11. P. 840 -852 | 23 | 88% | 0 |
9 | AHUJA, P , HUSAIN, A , SIDDIQUI, N , (2014) ESSENTIAL AMINOACID INCORPORATED GABA-PHTHALIMIDE DERIVATIVES: SYNTHESIS AND ANTICONVULSANT EVALUATION.MEDICINAL CHEMISTRY RESEARCH. VOL. 23. ISSUE 9. P. 4085 -4098 | 25 | 74% | 2 |
10 | OBNISKA, J , CHLEBEK, I , KAMINSKI, K , (2012) SYNTHESIS AND ANTICONVULSANT PROPERTIES OF NEW MANNICH BASES DERIVED FROM 3,3-DISUBSTITUTED PYRROLIDINE-2,5-DIONES. PART IV.ARCHIV DER PHARMAZIE. VOL. 345. ISSUE 9. P. 713 -722 | 21 | 91% | 4 |
Classes with closest relation at Level 1 |